Literature DB >> 7613600

Reporting guidelines for economic studies.

J Mason, M Drummond.   

Abstract

Mesh:

Year:  1995        PMID: 7613600     DOI: 10.1002/hec.4730040202

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  16 in total

1.  DEC methods for appraising new drugs. Are a foundation for the nice appraisal committee.

Authors:  B Campbell; R Peveler
Journal:  BMJ       Date:  1999-10-09

Review 2.  Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?

Authors:  C Bombardier; A Maetzel
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

3.  Challenges to the economic evaluation of new biotechnological interventions in healthcare.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1999-08       Impact factor: 4.981

Review 4.  Criteria for evaluating evidence on public health interventions.

Authors:  L Rychetnik; M Frommer; P Hawe; A Shiell
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

5.  Not playing with a full DEC: why development and evaluation committee methods for appraising new drugs may be inadequate.

Authors:  N Freemantle; J Mason
Journal:  BMJ       Date:  1999-05-29

6.  The dilemma of new drugs. Are costs rising faster than effectiveness?

Authors:  J Mason; N Freemantle
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

7.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Authors:  Jan B Oostenbrink; Marc A Koopmanschap; Frans F H Rutten
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

8.  Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature.

Authors:  K E Agro; C A Bradley; N Mittmann; M Iskedjian; A L Ilersich; T R Einarson
Journal:  Pharmacoeconomics       Date:  1997-01       Impact factor: 4.981

9.  A case for the adoption of pharmacoeconomic guidelines in Japan.

Authors:  S Ikeda; N Ikegami; A J Oliver; M Ikeda
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

Review 10.  The generalisability of pharmacoeconomic studies.

Authors:  J Mason
Journal:  Pharmacoeconomics       Date:  1997-06       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.